Bausch + Ströbel

Bausch + Ströbel is a provider of equipment and integrated solutions for the pharmaceutical industry. Its stated focus includes filling and closing systems, secondary packaging and containment solutions. The company presents itself as a partner to pharmaceutical manufacturers, emphasizing safe and efficient production and the coordinated interaction of people, machines and processes. Its equipment offerings cover several platform types. Ready-to-use (RTU) platforms process ready-to-use syringes, vials and cartridges; bulk platforms process vials and cartridges supplied in bulk; and flexible platforms are designed to handle different packaging containers on a single platform. The company also offers secondary-packaging and downstream-processing solutions for the handling, labelling and assembly of syringes, vials and cartridges. Its website describes integrated solutions as a way to connect production processes with patient needs and highlights intelligent automation, design and technical precision in addressing regulatory requirements and operational efficiency. Beyond machinery, Bausch + Ströbel offers LifeCycle Services intended to support equipment availability, performance, employee know-how and compliance across production and shutdown periods, as well as when disruptions occur. Service areas named on its website include Availability, Performance, Empowerment, Pharma Reliability, Digital and Annex 1 services. These encompass production analysis and optimization, technical modifications, training and practical support, digital services for production transparency and data-based optimization, and support for reliable aseptic processes and regulatory requirements. The supplied official-site material identifies the pharmaceutical industry as the company’s customer sector, but does not specify its founding date, founder, headquarters, ownership, corporate structure or geographic sales markets. The available evidence therefore supports describing Bausch + Ströbel as an active pharmaceutical-equipment and services provider, without assigning unverified corporate or historical details.

The supplied official-site evidence describes Bausch + Ströbel as a partner and solutions provider for the pharmaceutical industry, but does not provide a founding date, founder, early company history, ownership history or dated corporate milestones. A detailed chronological history cannot therefore be established from the available material. The company’s current portfolio, as presented on its official website, is organized around pharmaceutical filling and closing, packaging and containment. Its RTU platforms handle ready-to-use syringes, vials and cartridges. Bulk platforms process vials and cartridges supplied in bulk, while flexible platforms are intended to accommodate different packaging containers on one platform. The company also offers secondary-packaging and downstream-processing solutions for handling, labelling and assembling these containers. Its messaging connects integrated production solutions with process-to-patient safety, and emphasizes automation, considered design and technical precision in addressing regulatory and efficiency requirements. The official website also describes a service offering extending beyond machinery. B+S LifeCycle Services are presented as support for operating and continually improving production lines, with assistance planned around production and shutdowns and available in the event of disruption. Named service areas include Availability, Performance, Empowerment, Pharma Reliability, Digital and Annex 1 services. The Performance offering addresses analysis, stabilization and development of production processes, including technical modifications and work related to aseptic processes and Annex 1 topics. Empowerment focuses on building workforce competence through training and practical support, including topics such as ramp-up, Annex 1 adaptations and aseptic processes. Digital services are described as supporting production transparency and data-based process optimization. The available pages also show an emphasis on regulatory and operational needs, including Annex 1 and reliable aseptic processes. They do not date the introduction of these products or services, establish when the company entered particular markets, or identify management and corporate ownership. Accordingly, these offerings describe the company’s documented present-day activities rather than a dated development history.

A pharmaceutical-industry partner offering filling, closing, packaging and containment equipment alongside integrated production solutions and lifecycle services, with an emphasis on safety, efficiency, availability, performance and compliance.

• RTU platforms

  Platforms for filling and closing ready-to-use syringes, vials and cartridges.

• Bulk platforms

  Platforms for filling and closing vials and cartridges processed in bulk.

• Flexible platforms

  Flexible solutions for processing different packaging containers on one platform.

• Secondary-packaging solutions

  Solutions for safe handling, labelling and assembly of syringes, vials and cartridges.

• Containment solutions

  Containment solutions for the pharmaceutical industry.

1. 1Integrated Pharma Solutions | Filling, Packaging & Containmentbausch-stroebel.com
2. 2Services | Maximale Verfügbarkeit, Leistung und Compliancebausch-stroebel.com
3. 3Performancebausch-stroebel.com
4. 4Empowermentbausch-stroebel.com